Exchange Traded Concepts, LLC Summit Therapeutics Inc. Transaction History
Exchange Traded Concepts, LLC
- $3.87 Billion
- Q2 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 45,751 shares of SMMT stock, worth $919,595. This represents 0.01% of its overall portfolio holdings.
Number of Shares
45,751
Previous 59,986
23.73%
Holding current value
$919,595
Previous $248,000
43.55%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding SMMT
# of Institutions
138Shares Held
64.4MCall Options Held
1.06MPut Options Held
1.02M-
Baker Bros. Advisors LP New York, NY23.2MShares$467 Million2.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.82MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$159 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$82.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$59.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.04B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...